Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Mar;59(3):281–287. doi: 10.1097/FJC.0b013e31823fc3f5

Figure 6.

Figure 6

Urinary albumin to creatinine ratio (UACR) of sham and streptozotocin-induced diabetic (DM) rats treated with vehicle (V), aliskiren (Alisk), hydrochlorothiazide (HCTZ), amlodipine (Amlo), and their combination at baseline (open bars) and after six weeks of STZ-induction of diabetes and drug treatments (solid bars). Data are mean ± SEM. *P<0.05 vs. control; †P<0.05 vs. DM+V; ‡P<0.05 vs. DM+HCTZ; §P<0.05 vs. DM+Amlo; ||P<0.05 vs. DM+Alisk.